Emily Clement

Head of biology R&D at IMD-Pharma SAS
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Toulouse, Occitanie, France, FR

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • France
    • Biotechnology
    • 1 - 100 Employee
    • Head of biology R&D
      • Jan 2022 - Present

      Toulouse, Occitanie, France

    • France
    • Research Services
    • 700 & Above Employee
    • Researcher
      • Sep 2021 - Dec 2021

      Toulouse, Occitanie, France Study of anti-inflammatory compounds for the treatment of lung inflammation

    • France
    • Research Services
    • 700 & Above Employee
    • Postdoctoral Researcher
      • May 2019 - Sep 2021

      Toulouse, Occitanie, France Study of the efficacy of anti-inflammatory compounds for the treatment of psoriasis

    • France
    • Research Services
    • 700 & Above Employee
    • Étudiant doctorant
      • Nov 2014 - Feb 2019

      Région de Toulouse, France Role of adipocyte exosomes in melanoma progression: impact on metabolic remodeling towards fatty acid oxidation

    • France
    • Hospitals and Health Care
    • 200 - 300 Employee
    • Étudiant en master
      • Jan 2013 - Jun 2013

      Toulouse F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer

Education

  • Université Paul Sabatier Toulouse III
    Doctor of Philosophy - PhD, Cancer Research
    2014 - 2018
  • Université Paul Sabatier (Toulouse III)
    Master's degree, Oncologie et biologie du cancer
    2013 - 2014
  • Université Paul Sabatier (Toulouse III)
    Master 1, Bioingénierie
    2012 - 2013
  • Université Paul Sabatier (Toulouse III)
    Licence, Biochimie et biologie moléculaire
    2009 - 2012
  • Lycée Saint Etienne
    Baccalauréat, Scientifique
    2006 - 2009

Community

You need to have a working account to view this content. Click here to join now